DMRA
Damora Therapeutics, Inc.
20.20$
-2.1%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -37.6% | -57.2% | -21.4% | -22.1% | -91.7% | +60.0% | +12.5% | +11.1% | -30.0% | +871.4% | -83.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +8.5% | -11.0% | -25.5% | -40.4% | -7.8% | -32.7% | +116.1% | -3.3% | +13,856.8% | -88.0% | +7.4% | – | |
| – | – | – | – | – | -38.2% | +13.1% | +1.8% | -11.0% | +133.8% | +72.9% | +34.4% | – | |
| – | +4.3% | -1.4% | -19.7% | -16.6% | -28.5% | -3.8% | +31.6% | -7.7% | +6,290.9% | -84.8% | +13.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | -83.3% | -214.3% | – | +100.0% | – | – | -4.5% | +507.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.